Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: Imbria Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07023614

Phase 2, Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for
Growth Hormone Deficiency (GHD)
Location: Washington D.C. DC, Charlottesville VA,
Sponsor: Lumos Pharma

Sex: All

Age: 3 - 11

Code: NCT06948214

Phase 3, Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Washington D.C. DC, Midlothian VA, Philadelphia PA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Washington D.C. DC, Charlottesville VA, New York NY,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase 3, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for
Neoplasms, Head and Neck
Location: Washington D.C. DC, Columbia MD, Fredericksburg VA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase 3, Recruiting

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

for
HIV Infections
Location: Washington DC, Atlanta GA, Tampa FL, Miami FL,
Sponsor: ViiV Healthcare

Sex: All

Age: 6 - 12

Code: NCT05674656

Phase 1, Phase 2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Washington D.C. DC, Neptune City NJ, Vienna VA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for
Growth Hormone Deficiency
Location: Washington D.C. DC, Norfolk VA, Morristown NJ,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

Post-Procedural Manual Manipulation for Infant Ankyloglossia

for
Ankyloglossia, Breastfeeding Support
Location: Washington DC
Sponsor: Georgetown University

Sex: All

Age: 0

Code: NCT06830148

Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

for
Non-small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Frederick MD,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase 2, Phase 3, Recruiting

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

for
Thymoma, Thymic Carcinoma
Location: Washington D.C. DC, Hackensack NJ, Chicago IL,
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06248515

Phase 2, Recruiting

Phase IB/II of CPX-351 for Relapse Prevention in AML

for
Acute Myeloid Leukemia (AML) in Remission
Location: Washington D.C. DC, Philadelphia PA, Hackensack NJ
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT04990102

Phase 1, Phase 2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

for
Solid Tumor, MET Alteration
Location: Washington D.C. DC, Canton OH, Nashville TN
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06669117

Phase 1, Phase 2, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Washington DC, Baltimore MD, Durham NC, Boston MA,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase 1, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Washington D.C. DC, Arlington VA, Fairfax VA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Teligene US

Sex: All

Age: 18+

Code: NCT05168566

Phase 2, Recruiting

Addressing Genomic Disparities in Cancer Survivors

for
Hereditary Cancer, Genetic Testing
Location: Washington D.C. DC, New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT06073626

Recruiting

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

for
Prostate Cancer, Localized Prostate Carcinoma
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: Male

Age: 18+

Code: NCT07644598

Phase 2, Recruiting